Barbara Burwinkel

29.7k total citations · 1 hit paper
146 papers, 8.7k citations indexed

About

Barbara Burwinkel is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Barbara Burwinkel has authored 146 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Molecular Biology, 49 papers in Cancer Research and 45 papers in Genetics. Recurrent topics in Barbara Burwinkel's work include Epigenetics and DNA Methylation (25 papers), MicroRNA in disease regulation (22 papers) and Genetic factors in colorectal cancer (21 papers). Barbara Burwinkel is often cited by papers focused on Epigenetics and DNA Methylation (25 papers), MicroRNA in disease regulation (22 papers) and Genetic factors in colorectal cancer (21 papers). Barbara Burwinkel collaborates with scholars based in Germany, Sweden and United States. Barbara Burwinkel's co-authors include Andrey Turchinovich, Ludmila Weiz, Anne Langheinz, Hermann Brenner, Rongxi Yang, Lutz Philipp Breitling, Manfred W. Kilimann, Alexander Tonevitsky, Bernhard Korn and Andreas Schneeweiß and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Genetics.

In The Last Decade

Barbara Burwinkel

145 papers receiving 8.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Characterization of extracellular circulating microRNA

2011 1.6k citations Andrey Turchinovich, Barbara Burwinkel et al. profile →

Peers

Countries citing papers authored by Barbara Burwinkel

Since Specialization

Citations

This map shows the geographic impact of Barbara Burwinkel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Burwinkel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Burwinkel more than expected).

Fields of papers citing papers by Barbara Burwinkel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Burwinkel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Burwinkel. The network helps show where Barbara Burwinkel may publish in the future.

Co-authorship network of co-authors of Barbara Burwinkel

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Burwinkel. A scholar is included among the top collaborators of Barbara Burwinkel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Burwinkel. Barbara Burwinkel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CpG-biomarkers in tumor tissue and prediction models for the survival of colorectal cancer: A systematic review and external validation study 2023 ·Critical Reviews in Oncology/Hematology ·Tanwei Yuan, Dominic Edelmann, Jakob Nikolas Kather, Ziwen Fan, Katrin E. Tagscherer, Wilfried Roth, Melanie Bewerunge‐Hudler, Alexander Brobeil, Matthias Kloor, Hendrik Bläker, Barbara Burwinkel, Hermann Brenner, Michael Hoffmeister	2
2	Polymorphisms in the Angiogenesis-Related Genes EFNB2, MMP2 and JAG1 Are Associated with Survival of Colorectal Cancer Patients 2020 ·International Journal of Molecular Sciences ·Dominique Scherer, (unknown), Yesilda Balavarca, Réka Tóth, (unknown), Katharina Buck, (unknown), Akke Botma, Petra Seibold, Lina Jansen, Justo Lorenzo Bermejo, Korbinian Weigl, Axel Benner, Michael Hoffmeister, Alexis Ulrich, Hermann Brenner, Barbara Burwinkel, Jenny Chang‐Claude, Cornelia M. Ulrich	12
3	Genome-wide DNA methylation analysis reveals a prognostic classifier for non-metastatic colorectal cancer (ProMCol classifier) 2017 ·Gut ·Melanie Gündert, Dominic Edelmann, Axel Benner, Lina Jansen, Min Jia, Viola Walter, Phillip Knebel, Esther Herpel, Jenny Chang‐Claude, Michael Hoffmeister, Hermann Brenner, Barbara Burwinkel	32
4	Circulating microRNA’s as a diagnostic tool for hepatocellular carcinoma in a hyper endemic HIV setting, KwaZulu-Natal, South Africa: a case control study protocol focusing on viral etiology 2017 ·BMC Cancer ·Kurt Sartorius, Benn Sartorius, Anna Kramvis, Elvira Singh, Andrey Turchinovich, Barbara Burwinkel, T E Madiba, Cheryl A. Winkler	8
5	Reprogramming of the ERRα and ERα Target Gene Landscape Triggers Tamoxifen Resistance in Breast Cancer 2015 ·Cancer Research ·Verena Thewes, Ronald Simon, (unknown), Magdalena Schlotter, Tobias Anzeneder, Reinhard Büttner, Vladimı́r Beneš, Guido Sauter, Barbara Burwinkel, Robert I. Nicholson, Hans‐Peter Sinn, Andreas Schneeweiß, Ulrich Deuschle, Marc Zapatka, Stefanie Heck, Peter Lichter	35
6	Methylation status at HYAL2 predicts overall and progression-free survival of colon cancer patients under 5-FU chemotherapy 2015 ·Genomics ·Katrin Pfütze, Axel Benner, Michael Hoffmeister, Lina Jansen, Rongxi Yang, Hendrik Bläker, Esther Herpel, Alexis Ulrich, Cornelia M. Ulrich, Jenny Chang‐Claude, Hermann Brenner, Barbara Burwinkel	18
7	A Serum MicroRNA Signature Predicts Tumor Relapse and Survival in Triple-Negative Breast Cancer Patients 2014 ·Clinical Cancer Research ·Kristine Kleivi Sahlberg, Giulia Bottai, Bjørn Naume, Barbara Burwinkel, George A. Călin, Anne‐Lise Børresen‐Dale, Libero Santarpia	186
8	F2RL3 Methylation as a Biomarker of Current and Lifetime Smoking Exposures 2013 ·Environmental Health Perspectives ·(unknown), Rongxi Yang, Barbara Burwinkel, Lutz Philipp Breitling, Hermann Brenner	93
9	Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer 2012 ·Clinical Cancer Research ·Dharanija Madhavan, Manuela Zucknick, Markus Wallwiener, Katarina Ćuk, (unknown), Martina Scharpff, Sarah Schott, Jörg Heil, Andrey Turchinovich, Rongxi Yang, Axel Benner, Sabine Riethdorf, Andreas Trumpp, Christof Sohn, Klaus Pantel, Andreas Schneeweiß, Barbara Burwinkel	214
10	Smoking, F2RL3 methylation, and prognosis in stable coronary heart disease 2012 ·European Heart Journal ·Lutz Philipp Breitling, (unknown), Dietrich Rothenbacher, Barbara Burwinkel, Hermann Brenner	111
11	MicroRNA Signatures: Novel Biomarker for Colorectal Cancer? 2011 ·Cancer Epidemiology Biomarkers & Prevention ·Xiaoya Luo, Barbara Burwinkel, Shasha Tao, Hermann Brenner	207
12	Polimorfismo +49 A/G del gen del antígeno 4 del linfocito T citotóxico (CTLA-4) en la diabetes tipo 1: Asociación con el perfil de anticuerpos y citoquinas 2009 ·Revista médica de Chile ·(unknown), Ethel Codner, Barbara Burwinkel, (unknown), (unknown)	4
13	Asociación de la variante GHRd3 del receptor de la hormona de crecimiento con autoinmunidad en la diabetes tipo 1 2009 ·Revista médica de Chile ·Diego F. García‐Díaz, (unknown), Barbara Burwinkel, (unknown), (unknown)	1
14	Type 1 diabetes mellitus incidence in Santiago, Chile. Analysis by counties in the period 2000-2004 Incidencia de diabetes mellitus tipo 1 en Santiago de Chile: Análisis por comunas de la Region Metropolitana en el período 2000-2004 2006 ·Revista médica de Chile ·(unknown), Barbara Burwinkel, (unknown), Diego F. García‐Díaz, (unknown), (unknown), Francisco Bravo	1
15	Aurora kinases A and B and familial breast cancer risk 2006 ·Cancer Letters ·Sandrine Tchatchou, Michael Wirtenberger, Kari Hemminki, Christian Sutter, Alfons Meindl, Barbara Wappenschmidt, Marion Kiechle, Peter Bugert, Rita K. Schmutzler, Claus R. Bartram, Barbara Burwinkel	49
16	ARLTS1 variants and risk of colorectal cancer 2006 ·Cancer Letters ·Bernd Frank, Kari Hemminki, Hermann Brenner, Michael Hoffmeister, Jenny C. Chang, Barbara Burwinkel	19
17	Preliminary Evidence of FABP2 A54T Polymorphism Associated with Reduced Risk of Type 2 Diabetes and Obesity in Women from a German Cohort 2006 ·Hormone and Metabolic Research ·Elizabeth Fisher, Yong Li, Barbara Burwinkel, (unknown), Kurt Hoffmann, Matthias Möhlig, Joachim Spranger, Andreas Pfeiffer, Heiner Boeing, J. Schrezenmeir, Frank Döring	21
18	Identification of new acyl-CoA binding protein transcripts in human and mouse 2005 ·The International Journal of Biochemistry & Cell Biology ·Inke Nitz, Frank Döring, Jürgen Schrezenmeir, Barbara Burwinkel	26
19	Niveles plasmáticos de citoquinas IL-1ß, IL2 e IL-4 en niños diabéticos tipo 1 de diagnóstico reciente y su asociación con anticuerpos ß pancreáticos 2004 ·Revista médica de Chile ·(unknown), (unknown), (unknown), Barbara Burwinkel, Cecilia Albala B, (unknown)	17
20	Liver Glycogenosis Due to Phosphorylase Kinase Deficiency: PHKG2 Gene Structure and Mutations Associated with Cirrhosis 1998 ·Human Molecular Genetics ·Barbara Burwinkel, Susumu Shiomi, (unknown), Manfred W. Kilimann	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact